Get the Stockscreener App
19.38
1.41%
0.27
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $19.38, with a volume of 3.81M.
It is up +1.41% in the last 24 hours and up +2.49% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$19.11
Open:
$19.08
24h Volume:
3.81M
Relative Volume:
0.49
Market Cap:
$9.96B
Revenue:
$10.89B
Net Income/Loss:
$-241.00M
P/E Ratio:
-72.97
EPS:
-0.2656
Net Cash Flow:
$340.00M
1W Performance:
+2.22%
1M Performance:
+2.49%
6M Performance:
-36.46%
1Y Performance:
-33.86%
1-Day Range:
$19.03
$19.39
1-Week Range:
$18.65
$19.39
52-Week Range:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
19.38 | 9.82B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
577.81 | 204.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.33 | 55.88B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.38 | 39.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.76 | 35.68B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.13 | 34.85B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Reasons to Retain Baxter International Stock in Your Portfolio Now - TradingView — Track All Markets
Insider Sell: Will Baxter International Inc stock outperform international peersWeekly Trade Report & Weekly Stock Performance Updates - moha.gov.vn
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
Baxter International (BAX) Concludes Tender Offers with Final Se - GuruFocus
Baxter International completes final settlement of tender offers for senior notes - Investing.com India
Baxter International completes final settlement of tender offers for senior notes By Investing.com - Investing.com South Africa
Baxter International Completes Cash Tender Offers, Cuts Debt - TipRanks
Baxter International Finalizes Tender Offers Settlement - TradingView — Track All Markets
Risks Report: Is Baxter International Inc. stock a dividend growth opportunityCPI Data & Real-Time Sentiment Analysis - Улправда
A. D. Beadell Investment Counsel Inc. Takes $892,000 Position in Baxter International Inc. $BAX - Defense World
Is Baxter International Inc. stock affected by interest rate hikesJuly 2025 Summary & Stepwise Trade Signal Guides - ulpravda.ru
Is Baxter International Inc. stock a dividend growth opportunityJuly 2025 Analyst Calls & Weekly High Conviction Ideas - ulpravda.ru
Why pension funds invest in Baxter International Inc. stockJuly 2025 Trade Ideas & Daily Stock Trend Reports - ulpravda.ru
Baxter (BAX): Reassessing Valuation as Novum Infusion Pump Class Action Lawsuits Escalate - simplywall.st
Fiduciary Alliance LLC Grows Position in Baxter International Inc. $BAX - Defense World
U.S. Intravenous Solutions Market Is Going to Boom |Baxter International Inc., ICU Medical, Inc., Braun Melsungen Ag - openPR.com
Is Baxter International Inc. stock ready for breakoutEarnings Trend Report & Accurate Intraday Trade Tips - Улправда
Baxter International Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Baxter International Inc. (BAX): A Bull Case Theory - Finviz
August 2026 Options Now Available For Baxter International (BAX) - Nasdaq
Baxter International stock: Is BAX underperforming the health care sector? - MSN
Bragar Eagel & Squire is Investigating Certain Officers and - GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Baxter International (BAX) Is Up 7.5% After Class Action Over Infusion Pump Defects Filed - simplywall.st
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Levi & Korsinsky Invites Investors to SueWallSt After Baxter International, Inc. Stock Collapse - Stockhouse
Baxter International, Inc. Sued for Securities Law - GlobeNewswire
BAX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages - GlobeNewswire
BAXTER CLASS ACTION DEADLINE 12/15: Bragar Eagel & Squire, - GlobeNewswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors - GlobeNewswire
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care - TradingView — Track All Markets
Investors who lost money on Baxter International, Inc.(BAX) shou - GuruFocus
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Rutland Herald
Baxter International, Inc. (BAX) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Investors who lost money on Baxter International, Inc.(BAX) should contact The Gross Law Firm about pending Class ActionBAX - PR Newswire
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity - Bioscience Association Manitoba
Cullen Capital Management LLC Grows Position in Baxter International Inc. $BAX - Defense World
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - Morningstar
Investors in Baxter International, Inc. (BAX): Protect Your RightsContact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds Baxter International, Inc. (BAX) Investors of December 15, 2025 Deadline - Stockhouse
BAX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
BAX DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Baxter International, Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire
Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - MarketBeat
BAXTER CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Baxter Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile
Baxter International (BAX) Gets a Hold from Wells Fargo - The Globe and Mail
Investors in Baxter International, Inc. Should Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your RightsBAX - Your Wyoming Link
Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Investors who lost money on Baxter International, Inc.(BAX) - GlobeNewswire
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):